Impact of ICCAN on Cancer Treatment Completion and Quality of Life

Status:	Active, not recruiting
Conditions:	Breast Cancer, Lung Cancer, Colorectal Cancer, Cancer
Therapuetic Areas:	Oncology
Healthy:	No
Age Range:	21 - 80
Updated:	5/5/2018
Start Date:	November 2012
End Date:	November 2019

A Randomized Controlled Trial of the Impact of ICCAN on Cancer Treatment Completion and Quality of Life

The purpose of this 1 year study is to see if the ICCAN program is working, and to compare
the ICCAN program to the standard hospital services provided in New York City hospitals, like
meeting with a Social Worker or a Patient Navigator (a person who provides personal hospital
guidance).

Inclusion Criteria:

- fluent in English, Spanish, or Mandarin

- between the ages of 21-80 years old

- cancer patients currently receiving chemotherapy (started within the past month)
and/or radiation therapy (started within the past week), or

- scheduled to begin chemotherapy and/or radiation therapy within the next 2 months
(excluding surgery only patients)

- planning on remaining in the area for at least 1 year

Clinician Inclusion Criteria:

- Has an MD or DO degree

- Is the treating physician providing care to a patient enrolled to the study

Exclusion Criteria:

- diagnosed with Stage IV disease

- presence of untreated psychiatric disturbance (i.e. acute psychiatric symptoms which
require individual treatment) and/or cognitive impairment disorder (e.g., delirium or
dementia) verified by medical record sufficient to preclude completion of the
assessment measures, interview or informed consent

- has another family member already enrolled in ICCAN (as determined by patient report)

We found this trial at

sites

Memorial Sloan Kettering Cancer Center

1275 York Ave
New York, New York 10021

(212) 639-2000